Skip to main content
OpenTrials

Clinical trial condition

Gastric Adenocarcinoma

Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

191 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Gastric Adenocarcinoma trial results

Active, Not Recruiting

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

NCT03257163

Conditions
Digestive System Diseases, Digestive System Neoplasms, Epstein-Barr Virus Positive, +16 more
Locations
  • Emory University Atlanta, Georgia, United States
  • RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton Hamilton, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Montefiore Medical Center The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

NCT05002127

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +8 more
Locations
  • The Oncology Institute of Hope & Innovation Anaheim, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • NEXT Virginia Fairfax, Virginia, United States
View all 83 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

NCT04581473

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Peking University Shenzhen Hospital Shenzhen, Guangzhou, China
View all 24 locations
View Trial Details
Active, Not Recruiting

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

NCT03368963

Conditions
Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Neoplasms, +28 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details

Related conditions